For discerning immune cell signaling states associated with disease escalation in COVID-19 based on prospective patient samples in order to identify therapeutic targets to modulate inflammation in COVID-19 patients.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Matthew SpitzerResearch Location
United States of AmericaLead Research Institution
University of California-San FranciscoResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
For discerning immune cell signaling states associated with disease escalation in COVID-19 based on prospective patient samples in order to identify therapeutic targets to modulate inflammation in COVID-19 patients.